期刊
MOLECULAR AND CELLULAR BIOCHEMISTRY
卷 354, 期 1-2, 页码 67-75出版社
SPRINGER
DOI: 10.1007/s11010-011-0806-5
关键词
Brain ischemia; Induced pluripotent stem cells; Fibroblasts; Transcription factors; Transplantation therapy
类别
资金
- Natural Science Foundation of China [30570632]
- Pudong New Area, the leading health systems, medical personnel training programs [PWRq2007-03]
Stroke can cause permanent neurological damage, complications, and even death. However, there is no treatment exists to restore its lost function. Human embryonic stems transplantation therapy was a novel and potential therapeutic approach for stroke. However, as we have seen, the ethical controversy pertains to embryonic stem cell research. Human induced pluripotent stem cells (iPSCs) are the latest generation of stem cells that may be a solution to the controversy of using embryonic cells. In our study, we generated iPSCs from adult human fibroblasts by introduction of four defined transcription factors (Oct4, Sox2, Nanog, and Lin-28). And then, we investigated the efficacy of iPSCs transplantation therapy for stroke on the animal models of middle cerebral artery occlusion. Surprisingly, we found that transplanted iPSCs migrated to injured brain areas, and differentiated into neuron-like cells successfully. After 4-16 days iPSCs grafting, sensorimotor function of rats has been improved significantly. In one word, we may prove that iPSCs therapy in stroke to be an effective form of treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据